<unk>  is a quinolone antimicrobial that is FDA approved for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older.   Common adverse reactions include rosacea and seborrheic dermatitis which were reported in 1 adult patient treated with<unk> .
Ozenoxacin
Telithromycin
Azithromycin 
Roxithromycin
Dirithromycin
Enoxacin
Moxifloxacin 
Levofloxacin 